PTX3 and breast carcinoma: For instance, in breast cancer, PTX3 inhibits dihydrotestosterone- and FGF8b-driven cell proliferation (61), while elevated PTX3 levels, induced by TNF-α stimulation in a bone metastatic breast cancer cell line, promote cell migration, macrophage chemotaxis, and subsequent osteoclast differentiation (66).